HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human cytomegalovirus gene expression in long-term infected glioma stem cells.

Abstract
The most common adult primary brain tumor, glioblastoma (GBM), is characterized by fifteen months median patient survival and has no clear etiology. We and others have identified the presence of human cytomegalovirus (HCMV) gene products endogenously expressed in GBM tissue and primary cells, with a subset of viral genes being consistently expressed in most samples. Among these viral genes, several have important oncomodulatory properties, regulating tumor stemness, proliferation, immune evasion, invasion and angiogenesis. These findings lead us to hypothesize that a specific HCMV gene signature may be associated with GBM pathogenesis. To investigate this hypothesis, we used glioma cell lines and primary glioma stem-like cells (GSC) infected with clinical and laboratory HCMV strains and measured relative viral gene expression levels along several time points up to 15 weeks post-infection. While HCMV gene expression was detected in several infected glioma lines through week 5 post-infection, only HCMV-infected GSC expressed viral gene products 15 weeks post-infection. Efficiency of infection across time was higher in GSC compared to cell lines. Importantly, HCMV-infected GSC outlived their uninfected counterparts, and this extended survival was paralleled by increased tumorsphere frequency and upregulation of stemness regulators, such as SOX2, p-STAT3, and BMX (a novel HCMV target identified in this study). Interleukin 6 (IL-6) treatment significantly upregulated HCMV gene expression in long-term infected glioma cultures, suggesting that pro-inflammatory signaling in the tumor milieu may further augment HCMV gene expression and subsequent tumor progression driven by viral-induced cellular signaling. Together, our data support a critical role for long-term, low-level HCMV infection in promoting survival, stemness, and proliferation of GSC that could significantly contribute to GBM pathogenesis.
AuthorsEstefania Fiallos, Jonathon Judkins, Lisa Matlaf, Mark Prichard, Dirk Dittmer, Charles Cobbs, Liliana Soroceanu
JournalPloS one (PLoS One) Vol. 9 Issue 12 Pg. e116178 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID25549333 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-6
  • Viral Proteins
Topics
  • Brain Neoplasms (genetics, pathology, virology)
  • Cell Line, Tumor
  • Cell Transformation, Viral (genetics)
  • Cytomegalovirus (genetics)
  • Cytomegalovirus Infections (genetics)
  • Gene Expression Regulation, Neoplastic
  • Gene Expression Regulation, Viral (drug effects)
  • Glioma (genetics, pathology, virology)
  • Humans
  • Interleukin-6 (pharmacology)
  • Neoplastic Stem Cells (virology)
  • Signal Transduction (drug effects)
  • Viral Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: